Alglucerase cost makes dose recommendations ‘imperative’ Newsletter Article 17 February 2013 Pages: 2 - 2
Implement Japanese innovations in other healthcare systems Newsletter Article 17 February 2013 Pages: 2 - 2
Cost influences drug subsidy decisions in New Zealand Tracey Langsdale Newsletter Article 17 February 2013 Pages: 3 - 3
Debating the use of angioplasty and thrombolytics in acute MI Newsletter Article 17 February 2013 Pages: 4 - 4
Combine QOL and psychopathology to assess the impact of drugs Newsletter Article 17 February 2013 Pages: 5 - 5
Withdrawal of antihypertensive therapy seen as ‘appealing’ Newsletter Article 17 February 2013 Pages: 5 - 5
Explicit guidelines needed for inpatient psychiatric care Newsletter Article 17 February 2013 Pages: 5 - 6
Switching from cyclosporin to azathioprine is cost saving Newsletter Article 17 February 2013 Pages: 7 - 7
Cost-effective use of antivirals via home infusion service Newsletter Article 17 February 2013 Pages: 7 - 7
Topical terbinafine most cost effective for treating tinea Newsletter Article 17 February 2013 Pages: 8 - 8
Patients with osteoarthritis incur considerable costs Newsletter Article 17 February 2013 Pages: 8 - 8
Amoxicillin/clavulanic acid preferred in chronic bronchitis Newsletter Article 17 February 2013 Pages: 9 - 9
EPS-guided therapy increases charges in life-threatening arrhythmia Newsletter Article 17 February 2013 Pages: 9 - 9
Costs associated with drug-related hospitalisation Newsletter Article 17 February 2013 Pages: 10 - 10
IM hepatitis B revaccination recommended for nonresponders Newsletter Article 17 February 2013 Pages: 10 - 10
Cost effectiveness of calcipotriol vs dithranol for psoriasis Newsletter Article 17 February 2013 Pages: 12 - 12